Treatment of Finger Cellulitis

Initial Assessment and Antibiotic Selection

For typical non-purulent finger cellulitis, the American College of Physicians recommends selecting an antibiotic active against streptococci, which are the most common causative organisms 3, 1
First-line oral options include penicillin, amoxicillin, dicloxacillin, cephalexin (500 mg four times daily), and clindamycin, as recommended by the Infectious Diseases Society of America 1, 2, 3
Blood cultures or tissue aspirates are not routinely needed for typical cases of finger cellulitis, according to the Clinical Infectious Diseases guidelines 4, 1

A 5-day course of antimicrobial therapy is as effective as a 10-day course for uncomplicated cellulitis if clinical improvement occurs by day 5, as stated by the Infectious Diseases Society of America 3, 1, 2
Extend treatment only if the infection has not improved within the initial 5-day period, as recommended by the American College of Physicians 1, 2

MRSA is an unusual cause of typical cellulitis, and treatment specifically targeting MRSA is usually unnecessary, according to the Clinical Infectious Diseases guidelines 3
Consider MRSA coverage only in specific situations, such as cellulitis associated with penetrating trauma, evidence of MRSA infection elsewhere, history of injection drug use, purulent drainage, or systemic inflammatory response syndrome (SIRS), as recommended by the Infectious Diseases Society of America 2, 3

Elevate the affected finger to promote gravity drainage of edema and inflammatory substances, as recommended by the Clinical Infectious Diseases guidelines 3, 1, 2
Consider systemic corticosteroids (e.g., prednisone 40 mg daily for 7 days) in non-diabetic adult patients to reduce inflammation and hasten resolution, as stated by the American College of Physicians 3, 2

Most patients with finger cellulitis can be treated as outpatients, according to the American College of Physicians 1
Consider hospitalization if the patient has systemic inflammatory response syndrome (SIRS), altered mental status, hemodynamic instability, concern for deeper or necrotizing infection, poor adherence to therapy, or severe immunocompromise, as recommended by the Clinical Infectious Diseases guidelines 4, 2

Identify and treat any predisposing conditions, as recommended by the American College of Physicians 1, 2
For patients with frequent recurrences (3-4 episodes per year), consider prophylactic antibiotics such as oral penicillin, erythromycin, or intramuscular benzathine penicillin, as stated by the Infectious Diseases Society of America 1, 2

Don't extend treatment unnecessarily beyond 5 days if clinical improvement has occurred, as recommended by the American College of Physicians 2
Don't automatically add MRSA coverage for typical non-purulent cellulitis without specific risk factors, according to the Clinical Infectious Diseases guidelines 3, 2